Literature DB >> 22278236

Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis.

Magdalena Janina Laska1, Tomasz Brudek, Kari Konstantin Nissen, Tove Christensen, Anné Møller-Larsen, Thor Petersen, Bjørn Andersen Nexø.   

Abstract

Multiple sclerosis (MS) is considered to be an autoimmune disease with an unknown cause and with immune system dysregulation. Among environmental factors, viruses are most often connected with the etiology of MS. Human endogenous retroviruses (HERVs) constitute 5 to 8% of human genomic DNA and have been detected as transcripts and proteins in the central nervous system (CNS) and peripheral blood, frequently in the context of neuroinflammation. HERV-Fc1, which belongs to the HERV-H/F family, has received our attention largely because of the genetic association with MS. We studied the expression of a capsid (Gag) protein of HERV-H/F origin by flow cytometry in peripheral blood mononuclear cells (PBMCs) from healthy controls and from MS patients with nonactive or active disease. There was a significant increase in HERV-H/F Gag expression in CD4(+) (P < 0.001) and CD8(+) (P < 0.001) T lymphocytes and in monocytes (P = 0.0356) in PBMCs from MS patients with active disease. Furthermore, we have undertaken the first rigorous SYBR green-based absolute quantitative PCR (Q-PCR) evaluation approach to quantify extracellular HERV-Fc1 RNA viral loads in plasma from MS patients and healthy controls. We found a 4-fold increase in extracellular HERV-Fc1 RNA titers in patients with active MS compared with healthy controls (P < 0.001). These findings strengthen the link between HERV-Fc1 and the pathology of MS. The cause and biological consequences of these differential expression levels will be the subject of further investigation. HERV-Fc1 biology could be a compelling area for understanding the pathology of MS and possibly other autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278236      PMCID: PMC3302483          DOI: 10.1128/JVI.06723-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

Review 1.  Infectious causes of multiple sclerosis.

Authors:  Gavin Giovannoni; Gary R Cutter; Jan Lunemann; Roland Martin; Christian Münz; Subramaniam Sriram; Israel Steiner; Margaret R Hammerschlag; Charlotte A Gaydos
Journal:  Lancet Neurol       Date:  2006-10       Impact factor: 44.182

2.  Isolation of a retrovirus from multiple sclerosis patients in self-generated Iodixanol gradients.

Authors:  A Møller-Larsen; T Christensen
Journal:  J Virol Methods       Date:  1998-08       Impact factor: 2.014

3.  Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis.

Authors:  J A Garson; P W Tuke; P Giraud; G Paranhos-Baccala; H Perron
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

4.  Characterization of retroviruses from patients with multiple sclerosis.

Authors:  T Christensen; A W Jensen; M Munch; S Haahr; P D Sørensen; H Riemann; H J Hansen; A Møller-Larsen
Journal:  Acta Neurol Scand Suppl       Date:  1997

5.  The Danish Multiple Sclerosis Registry: a 50-year follow-up.

Authors:  N Koch-Henriksen
Journal:  Mult Scler       Date:  1999-08       Impact factor: 6.312

6.  Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.

Authors:  J B Johnston; C Silva; J Holden; K G Warren; A W Clark; C Power
Journal:  Ann Neurol       Date:  2001-10       Impact factor: 10.422

7.  Definition and variation of human endogenous retrovirus H.

Authors:  Patric Jern; Göran O Sperber; Jonas Blomberg
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

8.  Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy.

Authors:  Giuseppe Mameli; Caterina Serra; Vito Astone; Massimiliano Castellazzi; Luciana Poddighe; Enrico Fainardi; Walter Neri; Enrico Granieri; Antonina Dolei
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

9.  Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?

Authors:  Bernd Krone; John M Grange
Journal:  Autoimmune Dis       Date:  2010-12-20

10.  B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.

Authors:  Tomasz Brudek; Tove Christensen; Lars Aagaard; Thor Petersen; Hans J Hansen; Anné Møller-Larsen
Journal:  Retrovirology       Date:  2009-11-16       Impact factor: 4.602

View more
  35 in total

1.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

2.  A new theory on autoimmunity with reference to multiple sclerosis.

Authors:  Bjørn A Nexø
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

3.  Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells.

Authors:  A Møller-Larsen; T Brudek; T Petersen; E L Petersen; M Aagaard; D T Hansen; T Christensen
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

Review 4.  Multiple sclerosis: autoimmunity and viruses.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

Review 5.  Up-to-date knowledge about the association between multiple sclerosis and the reactivation of human endogenous retrovirus infections.

Authors:  Borros Arneth
Journal:  J Neurol       Date:  2018-02-08       Impact factor: 4.849

Review 6.  Emerging roles for endogenous retroviruses in immune epigenetic regulation.

Authors:  Carmen A Buttler; Edward B Chuong
Journal:  Immunol Rev       Date:  2021-11-23       Impact factor: 12.988

7.  Transposable element dysregulation in systemic lupus erythematosus and regulation by histone conformation and Hsp90.

Authors:  Maurer Kelly; Shi Lihua; Zhang Zhe; Song Li; Paucar Yoselin; Petri Michelle; E Sullivan Kathleen
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

Review 8.  Role of pathogens in multiple sclerosis.

Authors:  Jane E Libbey; Matthew F Cusick; Robert S Fujinami
Journal:  Int Rev Immunol       Date:  2013-11-22       Impact factor: 5.311

Review 9.  HSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination.

Authors:  Raquel Bello-Morales; Sabina Andreu; Inés Ripa; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

10.  No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.

Authors:  Kari K Nissen; Magdalena J Laska; Bettina Hansen; Finn S Pedersen; Bjørn A Nexø
Journal:  Virol J       Date:  2012-09-08       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.